Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
Homology Medicines Inc is a US-based genetic medicines company dedicated to transforming the lives of patients suffering from rare genetic diseases with significant unmet medical needs by curing the underlying cause of the disease. Its proprietary platform is designed to utilize its human hematopoietic stem cell derived adeno-associated virus vectors (AAVHSCs) to deliver genetic medicines in vivo either through a gene therapy or nuclease-free gene editing modality across a range of genetic disorders.
| Last: | $4.51 |
|---|---|
| Change Percent: | -5.05% |
| Open: | $4.74 |
| Close: | $4.75 |
| High: | $4.77 |
| Low: | $4.36 |
| Volume: | 136,264 |
| Last Trade Date Time: | 02/27/2026 12:45:17 pm |
| Market Cap: | $47,494,799 |
|---|---|
| Float: | 5,266,263 |
| Insiders Ownership: | 0.49% |
| Institutions: | 24 |
| Short Percent: | N/A |
| Industry: | Biotechnology & Life Sciences |
| Sector: | Healthcare |
| Website: | https://www.q32bio.com |
| Country: | US |
| City: | Waltham |
Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.
**MWN-AI FAQ is based on asking OpenAI questions about Q32 Bio Inc. (NASDAQ: QTTB).
Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.
Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.
